Requesting a Call:
E-mail us
Emerald Hill, Harare
The Touchpoints Study is an implementation research project designed to improve continuity of HIV prevention services through timely return for scheduled long-acting Lenacapavir (LEN) injections.
LEN is a long-acting injectable medicine used for HIV prevention, offering an additional prevention option for people who may benefit from alternatives to daily oral PrEP. Maintaining timely attendance for scheduled injections is essential to ensuring continuity of protection.
The project will work with healthcare providers and clients to co-design, implement and evaluate simple, acceptable and practical reminder and follow-up strategies (touchpoints) that encourage clients to return to health facilities within their scheduled injection windows.
Using a combination of quantitative and qualitative research methods, the study will explore which approaches work best, their feasibility within routine healthcare settings, and how they can be adapted to meet the needs of different populations.
To evaluate the acceptability, feasibility and appropriateness of co-designed, low-burden strategies that support clients to return on time for their scheduled LEN injections across different clinical settings in Zimbabwe.
Promoting timely return for scheduled LEN injections and reducing missed reinjection appointments.
Co-designing practical, low-burden touchpoints that respond to clients’ preferences and circumstances.
Working with clinic staff to identify feasible approaches that can be integrated into existing service delivery systems without creating unnecessary workload.
Assessing the acceptability, feasibility, appropriateness, adoption, fidelity, reach and cost of the different strategies.
Understanding the experiences, preferences and challenges of people accessing LEN, including populations not traditionally reached through PrEP services.
Producing findings to guide improvements in HIV prevention programming and inform future implementation and scale-up.
The study will engage diverse populations who may benefit from LEN and other PrEP options, including:
The project will be implemented at four selected health service delivery sites across Zimbabwe:
Masvingo
Chitungwiza
Mashonaland Central
Bulawayo
Our Newsletter
© Developed by Pangaea Zimbabwe 2026